Board of Directors
David Kavanagh, PhD,
Board Director
Vice President
Site Head & Managing Director,
Genuity Science (Ireland) Ltd.
“Genomics is the key to unlocking the potential of precision medicine.”
David leads Genuity Science’s global clinical operations and programmes and is the managing director of our Ireland site. David is primarily responsible for the establishment and management of long-term research partnerships with world leading health systems, biobanks and cohort research groups. The work of David and his team supports the ethical and responsible sourcing of human biological samples and deep phenotype data, the downstream project management of related genomic analysis projects and the support of the ongoing needs of our academic and healthcare partners. The team’s efforts ensure that our research teams have access to the highest quality data in order to deliver breakthrough insights to our pharma and biotech customers.
David has extensive experience in life sciences and has held leadership roles in several high-growth academic and commercial life science organisations including Systems Biology Ireland, located at University College Dublin and CompareNetworks, a San Francisco-based life science marketing company. David’s areas of specialty include life science innovation and commercialisation, operational & high performing team development in life science start-up environments, genomics, systems biology, connected health, life science text mining and healthcare consulting.
David holds a PhD in Biochemistry from University College Dublin.
Jonathan Lanfear, MBA
Board Director
President & Chief Executive Officer, HiberCell
President and Chief Executive Officer, Jonathan Lanfear, is an accomplished biopharmaceutical executive with more than 25 years of experience in the life sciences industry and has demonstrated distinct success in creating and driving strategies, building and developing teams, establishing R&D partnerships, and creating new business opportunities. Prior to joining HiberCell, Jonathan was a Principal at Lanfear Advisors LLC, where he provided Corporate Strategy and Operations consultancy services to public and private sector biotech and bio/pharmaceutical companies. Prior to establishing his consulting practice in 2020, he was the Global Head of R&D Business Development at Takeda Pharmaceuticals, based in Cambridge, MA.
Before joining Takeda in 2011, Jonathan spent approximately eight years at Pfizer Inc as a Senior Director and Transactions Lead in the Worldwide Business Development, Strategy, & Innovation (WWBDS&I) organisation based in New York. His prior roles also include Biotechnology Equity Research at AG Edwards/Wachovia and Team Leader, GMP Operations and Downstream Processing at Searle/Pharmacia (prior to the company’s acquisition by Pfizer). Over his career, Jonathan has led hundreds of transactions of all types, integrated acquired entities, lead operations, and managed strategic alliances/partnerships. He holds a Bachelor’s degree in Chemical Engineering and a Master’s degree in Bioengineering, both from the University of Michigan (Ann Arbor), along with an MBA from Washington University (St. Louis). Jonathan is also a member of the Board of Directors of Molecular Templates, an oncology focused, publicly traded company based in New Jersey.
Colin Beecham
Board Director
SVP, Finance, Genuity Science
Colin joined Genuity Science in 2015 overseeing all aspects of finance and administration for the Irish entity (Genomics Medicine Ireland Ltd.). He played a major role in building GMI from its inception including the integration and restructure of GMI into Genuity Science, and is a key business leader in the organisation.
Prior to joining the company, Colin worked in senior financial positions in global manufacturing companies, initially in the UK and other parts of Europe. In Ireland, he has worked for a number of companies, helping them to solve issues, create value, maximise growth and improve business performance. His experience crosses many multi-functional areas and has been applied to the rapid scaling of Genuity Science.
Colin is a Qualified Accountant and Treasurer, and he received his Economics and Law degree from Durham University, England.
